Deciphering the molecular mechanisms of Maxing Huoqiao Decoction in treating pulmonary fibrosis via transcriptional profiling and circRNA-miRNA-mRNA network analysis
Open Access
- 12 March 2023
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 115, 154754
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic diseaseJCI Insight, 2016
- Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volumeThorax, 2016
- Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and HedgehogNature Reviews Nephrology, 2016
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2015
- MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in AnimalsAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological ReviewClinical Reviews in Allergy & Immunology, 2010
- Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosisRespiratory Medicine, 2010
- Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2009